To assess the efficacy of Guduchyadi churna and Virechana karma in the management of Non-Alcoholic Fatty Liver Disease.

A comparative clinical study to assess the efficacy of Guduchyadi Churna and Virechana Karma in the management of Non-Alcoholic Fatty Liver Disease. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106105

Enrollment

Registered

2026-03-13

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed and confirmed cases of NAFLD based on the subjective and objective criteria. Patients with grade I & grade II fatty liver as per USG findings Patient who are willing to enroll in the study.

Exclusion criteria

Exclusion criteria: Patient who does not follow inclusion criteria

Design outcomes

Primary

Measure	Time frame
It is expected that there will be a significant improvement in the subjective and objective parameters in the patients of NAFLD.Timepoint: 60 days	—

Secondary

Measure	Time frame
It is expected that Null hypothesis (H0) is false and the trial drug and Virechana karma has potential effect in the management of NAFLD.Timepoint: 60 days	—

Countries

India

Contacts

Public ContactProf Sunanda Ramakrishna Pedhekar

Institute of Medical Sciences, Banaras Hindu University

drsrpedhekar@gmail.com9423241800

Outcome results